Globus Medical (GMED) PT Lowered to $68 at Truist Securities Following EPS Miss

May 9, 2025 9:01 AM

Truist Securities analyst Richard Newitter lowered the price target on Globus Medical (NYSE: GMED) to $68.00 (from $80.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found